ISIAT 2023

Thursday October 5th, 2023

FIRST SESSION

Placebo effect in osteoarthritis: why not use it in our advantage?
G. De Campos (Sao Paolo, Brazil)

Friday October 6th, 2023

SECOND SESSION

Autologous peripheral blood stem cells (PBSC) in hip osteoarthritis: evidence and personal data
M. Krochmalski (Lódź, Poland)

Should we implant or should we inject the stem cells?
J.M. Pers (Montpellier, France)

The role of IA treatment to improve “self-healing” in the management of musculoskeletal disorders
A. Mobasheri (Oulu, Finland)

THIRD SESSION

Intra-articular PRP injections: mechanisms of action and their degree of efficacy
I. Andia Ortiz (Barakaldo, Spain)

FOURTH SESSION

Microsponges for intra-articular treatment: new evidence
A. Rinaldi (Rome, Italy)

ORAL COMMUNICATIONS ON INTRA-ARTICULAR THERAPY

ASSESSMENT OF SELECTED MOLECULAR FACTORS IN CORRELATION WITH DISEASE PROGRESSION AND EFFECTIVENESS OF HSCs CD34+ TREATMENT IN PATIENTS WITH KNEE OSTEOARTHRITIS
J. Kryczka, K. Baran, E. Brzezianska-Lasota, M. Krochmalski (Lodz, Poland)

THERAPEUTIC EFFICACY OF INTRA-ARTICULAR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs) IN THE TREATMENT OF INFLAMMATORY ARTHRITIS: TIME FOR AWARENESS AND ESTABLISHING A ROLE IN ARTHRITIS PATIENT CARE IN 2023 AND BEYOND
K.H. Yoon (Singapore)

ROUND TABLE

Eurovisco recommendations: an overview
T. Conrozier (Belfort, France)

GRIIP consensus statement: intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis
M. Lamontagne (Montreal, Canada)

Saturday October 7th, 2023

FIFTH SESSION

Epidemiological profile of injection therapy in Brazil
P. Hamdan (Rio de Janeiro, Brazil)

Brazilian Consensus on TMJ (Ear-jaw articulation) viscosupplementation
R. Tesch (Rio de Janeiro, Brazil)

Peritendinous injections: update of tecniques and evidence
D. Diracoglu (Istanbul, Turkey)

SIXTH SESSION

Intra-articular injections for the treatment of trapeziometacarpal arthritis
M.A. Malahias (Athens, Greece)

INDUSTRY-SPONSORED LECTURE

GRÜNENTHAL SATELLITE LECTURE
TRANSIENT RECEPTOR POTENTIAL VANILLOID 1 (TRPV1): A NOBEL FUTURE FOR OA KNEE PAIN
A. Mobasheri (Oulu, Finland)

Please note that only presentations approved by consensus are available.